Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

TFF1 anticorps

Cet anticorps Souris Monoclonal détecte spécifiquement TFF1 dans IF, FACS et IHC (f). Il présente une réactivité envers Humain.
N° du produit ABIN6938525

Aperçu rapide pour TFF1 anticorps (ABIN6938525)

Antigène

Voir toutes TFF1 Anticorps
TFF1 (Trefoil Factor 1 (TFF1))

Reactivité

  • 83
  • 17
  • 16
  • 14
  • 10
Humain

Hôte

  • 46
  • 46
Souris

Clonalité

  • 50
  • 42
Monoclonal

Conjugué

  • 56
  • 8
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
Cet anticorp TFF1 est non-conjugé

Application

  • 54
  • 38
  • 34
  • 29
  • 17
  • 13
  • 9
  • 8
  • 6
  • 5
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Immunofluorescence (IF), Flow Cytometry (FACS), Immunohistochemistry (Formalin-fixed Sections) (IHC (f))

Clone

TFF1-2133
  • Specificité

    It recognizes a polypeptide of 6.5 kDa, identified as pS2 estrogen-regulated protein. Its epitope is located in the c-terminus of human pS2 protein. pS2 is a trefoil peptide. Trefoil peptides are protease resistant molecules secreted throughout the gut that play a role in mucosal healing. These peptides contain three intra-chain disulfide bonds, forming the trefoil motif, or P-domain. pS2 is known to form dimers and this dimerization is thought to play a role in its protective and healing properties. About 60 % of breast carcinomas are positive for pS2. Staining is cytoplasmic, often with localization to the Golgi apparatus. pS2 is shown to be localized in normal stomach mucosa, gastric fluid, goblet cells in the colon and small intestine, and in ulcerations of the gastrointestinal tract. Several studies have shown that pS2 is primarily expressed in estrogen receptor-positive breast tumors and it may define a subset of estrogen-dependent tumors that displays an increased likelihood of response to endocrine therapy.

    Réactivité croisée (Details)

    Human.

    Purification

    1.0mg/ml of Ab purified from Bioreactor by Protein A/G.

    Immunogène

    Recombinant full-length human TFF1 protein

    Isotype

    IgG2b kappa
  • Indications d'application

    Known_Application: Flow Cytometry (1-2 μg/million cells), ,Immunofluorescence (1-2 μg/mL),Immunohistochemistry (Formalin-fixed) (1-2 μg/mL for 30 minutes at RT),(Staining of formalin-fixed tissues requires heating tissue sections in 10 mM Tris with 1 mM EDTA, pH 9.0, for 45 min at 95°C followed by cooling at RT for 20 minutes), Optimal dilution for a specific application should be determined.

    Positive_Control: MCF-7 cells, Breast or Ovarian carcinoma.

    Restrictions

    For Research Use only
  • Concentration

    1.0 mg/mL

    Buffer

    Prepared in 10 mM PBS, WITHOUT BSA and Azide.

    Agent conservateur

    Azide free

    Stock

    -20 °C,-80 °C

    Stockage commentaire

    Antibody without azide store at -20 to -80 °C. Antibody is stable for 24 months. Non-hazardous.

    Date de péremption

    24 months
  • Antigène

    TFF1 (Trefoil Factor 1 (TFF1))

    Autre désignation

    TFF1

    Sujet

    BCEI, Breast Cancer Estrogen Inducible Protein, Gastrointestinal Trefoil Protein, Gastrointestinal trefoil protein pS2, HP1A, HPS2, pNR2, TFF1, Trefoil Factor 1,pS2 / pNR-2 / TFF1 (Estrogen-Regulated Protein)
    Cellular localisation: Cytoplasmic

    Poids moléculaire

    6.5kDa

    ID gène

    7031, 162807

    UniProt

    P04155

    Pathways

    EGFR Signaling Pathway
Vous êtes ici:
Chat with us!